Transforming Growth Factor-β Protects against Inflammation-Related Atherosclerosis in South African CKD Patients

Table 6

Producer status and transforming growth factor-β1 in genotyped study participants (n=111).

Producer status	High	Intermediate	Low	P-value
Frequency	81 (73.0%)	22 (19.8%)	8 (7.2%)	0.649
TGF-β1 levels (ng/ml); (Median; IQR)	52.9 (41.8 – 64.6)	45.8 (35.8 – 68.0)	46.8 (42.8 – 82.5)

TGF-β1: transforming growth factor β1. P-value was calculated using Kruskal-Wallis test and compared TGF-β1 levels across the three comparison groups. Post hoc analysis did not showed any significant difference among the three comparison groups (p>0.05).